Home / Import refusals / NUV-3849643-9/30002/1

NUV-3849643-9/30002/1

Eli Lilly & Company — FEI 1819470

Recent inspections

  • 1298628 (NAI Fri Jan 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1270621 (VAI Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1260339 (VAI Thu Mar 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229895 (NAI Wed Jan 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1217806 (VAI Fri Sep 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 799-3629208-1/20001/1 (Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-3862393-4/10001/1 (Wed Jan 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0166087-1/20001/1 (Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3852229-1/10002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3852229-1/40002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
November 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCP54 LISPRO INSULIN (ANTI-DIABETIC)
Charges
179